A novel model for Ki67 assessment in breast cancer

The current state of breast cancer classification

(2012) G. Viale   ANNALS OF ONCOLOGY

Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer

(2012) Z M A Mohammed et al.   BRITISH JOURNAL OF CANCER

Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies

(2011) Quinci Romero et al.   BMC CANCER

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies

(2011) S Fasanella et al.   Diagnostic Pathology

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

(2011) M. Dowsett et al.   JNCI-Journal of the National Cancer Institute

Current and emerging biomarkers in breast cancer: prognosis and prediction

(2010) Marion T Weigel et al.   ENDOCRINE-RELATED CANCER

Ki67 in breast cancer: prognostic and predictive potential

(2010) Rinat Yerushalmi et al.   LANCET ONCOLOGY

Theory of sampling and its application in tissue based diagnosis

(2009) Klaus Kayser et al.   Diagnostic Pathology

Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients

(2008) R. Stuart-Harris et al.   BREAST